Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Hospital-acquired Disease Testing Market – Market Insights

Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients which occurs due to adverse reaction caused by infectious toxin agents during medical care, and were absent at the time of admission. Hospital-acquired infections result in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and higher mortality rate. Pathogens responsible for hospital-acquired diseases include viruses, fungal parasites, and bacteria.

Hospital-acquired diseases also include catheter-related blood stream infections, surgical site infections, ventilator-associated pneumonia, and catheter-associated urinary tract infection. The technique used for prevention, diagnosis, and testing of hospital-acquired diseases are microarray, PCR, and solid phase hybridization. Urinary tract infections are most common in patients using urinary catheters as the urethra is located close to the anus, which increases the chances of bacterial invasion from the large intestine into the urinary tract.

The global hospital-acquired disease testing market is expected to be valued at US$ 925.4 million in 2019, and is expected to exhibit a CAGR of 20.0% over the forecast period (2019-2027).

Figure 1. Global Hospital-acquired Disease Testing Market Value (US$ Mn), by Region, 2019

Hospital-acquired Disease Testing  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing incidence of hospital acquired infections is expected to propel the market growth over the forecast period

Rising incidence of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and others are expected to drive growth of the hospital-acquired disease testing market over the forecast period. For instance, according to data published during the National Healthcare Safety Network Bloodstream Infection Surveillance in March 2018, around 30,000 CLABSI cases are reported every year in the U.S. CLABSI can prolong the hospital stay, which can increase the cost burden on patients and also lead to mortality.

Furthermore, according to the statistics published by the International Society for Infectious Diseases in March 2018, around 250,000 cases of blood stream infections are reported every year in the U.S. Among these, around 80,000 are catheter-related bloodstream infections (CRBSI) which occur in intensive care units.

Figure 2. Global Hospital-acquired Disease Testing Market Value, (US$ Million), 2016-2027

Hospital-acquired Disease Testing  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing launches of advanced and efficient testing tools and kits are expected to fuel the growth of the hospital-acquired disease testing market

Manufacturers are focusing on development of advanced testing kits to enhance the efficiency of hospital-acquired disease diagnosis. For instance, in December 2019, F.Hoffmann-La Roche Ltd. received the U.S. Food and Drug Administration (FDA) approval for cobas vivoDx MRSA, a diagnostic test designed to detect the Methicillin-resistant Staphylococcus aureus (MRSA) bacteria. The approval of cobas vivoDx MRSA is intended to aid in the control and prevention of the Methicillin-resistant Staphylococcus aureus (MRSA) infections in healthcare settings.

However, decreasing prevalence of nosocomial infections due to the availability of advanced hospital-acquired disease tests in developed countries is likely to hinder the market growth in near future.

Key Players

Major players operating in the global hospital-acquired disease testing market include Luminex Corporation, Diatherix Laboratories, Life Technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomérieux, and Cepheid.

Hospital-acquired infections are acquired by the patient under medical care. The most common types of hospital-acquired infections are urinary tract infections, bloodstream infections, Methicillin-resistant Staphylococcus aureus (MRSA), pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is a major factor driving the growth of the hospital-acquired disease testing market. Devices such as catheters and ventilators that are used in modern care facilities are also among the primary causes of these infections.

Market Dynamics

Key players in the market are focused on adoption of expansion strategies such as mergers and acquisitions, collaborations, and partnerships in order to expand their product portfolio and global presence in the hospital-acquired disease testing market. For instance, in April 2019, Meridian Bioscience, Inc. entered an agreement to acquire GenePOC Inc., a Canada based provider of molecular diagnostic instruments and assays. Through this acquisition, Meridian Bioscience will include state-of-the art revogene molecular diagnostics platform of GenePOC Inc. in its diagnostics portfolio.

Key features of the study:

  • This report provides in-depth analysis of the global hospital-acquired disease testing market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Luminex Corporation, Diatherix laboratories, Life technologies, Cantel Medical Corporation, Meridian Biosciences Inc, Nordion Inc, Qiagen GmbH, F.Hoffmann-La Roche Ltd., Biomérieux, and Cepheid.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, product Type up-gradation, market expansion, and marketing tactics
  • The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hospital-acquired disease testing market

Detailed Segmentation:

  • Global hospital-acquired disease testing Market, By Test Type:
    • Urinary Tract Infection
    • Surgical Site Infection
    • Pneumonia Stents
    • Blood Stream Infection
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
    • Others
  • Global hospital-acquired disease testing Market, By Region:
    • North America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus (MRSA)
        • Others
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Luminex Corporation*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Diatherix Laboratories
    • Life Technologies
    • Cantel Medical Corporation
    • Meridian Biosciences Inc.
    • Nordion Inc.
    • Qiagen GmbH
    • Hoffmann-La Roche Ltd.
    • Biomérieux
    • Cepheid

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Test Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • Epidemiology
    • Preventive Initiatives
  4. Global Hospital-acquired Disease Testing Market, By Test Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Urinary Tract Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Surgical Site Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Pneumonia Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Blood Stream Infection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Methicillin-resistant Staphylococcus Aureus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Hospital-acquired Disease Testing Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Region, 2017–2027
    • North America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  6. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Luminex Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Diatherix laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Life Technologies
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cantel Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Meridian Biosciences Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nordion Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Qiagen GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Biomérieux
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cepheid Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 33 market data tables and 30 figures on "Hospital-acquired Disease Testing Market” - Global forecast to 2027.

Frequently Asked Questions

This report provides in-depth analysis of the global hospital-acquired disease testing market and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2019 – 2027). The report also provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Key segments covered in the report include: o By Test Type o By Region
The report provides also provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
Increasing incidence of hospital-acquired diseases, government initiatives to control and prevent hospital-acquired infections, and technological advancements in product design.
The report profiles leading players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner